We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RC
1551
Ready Capital
RC
$297M
$130K ﹤0.01%
15,925
– –
AMWD
1552
DELISTED
American Woodmark
AMWD
$130K ﹤0.01%
1,656
– –
KMX icon
1553
CarMax
KMX
$8.46B
$130K ﹤0.01%
1,770
-116
-6% -$8.36K
JNPR
1554
DELISTED
Juniper Networks
JNPR
$130K ﹤0.01%
3,560
– –
HYLB icon
1555
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.48B
$130K ﹤0.01%
3,660
-643
-15% -$22.7K
MORF
1556
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$130K ﹤0.01%
3,804
– –
AVPT icon
1557
AvePoint
AVPT
$2.9B
$130K ﹤0.01%
12,433
-2,806
-18% -$24.3K
PCRX icon
1558
Pacira BioSciences
PCRX
$928M
$129K ﹤0.01%
4,526
– –
STBA icon
1559
S&T Bancorp
STBA
$1.81B
$129K ﹤0.01%
3,866
– –
NWN icon
1560
Northwest Natural Holdings
NWN
$2.14B
$129K ﹤0.01%
3,571
– –
RWL icon
1561
Invesco S&P 500 Revenue ETF
RWL
$10B
$129K ﹤0.01%
1,392
-60
-4% -$5.51K
HLIT icon
1562
Harmonic Inc
HLIT
$1.51B
$129K ﹤0.01%
10,947
– –
APPN icon
1563
Appian
APPN
$2.58B
$129K ﹤0.01%
4,169
– –
COMP icon
1564
Compass
COMP
$10B
$129K ﹤0.01%
35,721
+6,035
+20% +$22.1K
EWTX icon
1565
Edgewise Therapeutics
EWTX
$4.7B
$128K ﹤0.01%
7,112
+1,361
+24% +$23.7K
TWO
1566
Two Harbors Investment
TWO
$1.27B
$128K ﹤0.01%
9,668
– –
BKD icon
1567
Brookdale Senior Living
BKD
$3.03B
$128K ﹤0.01%
18,689
– –
JKHY icon
1568
Jack Henry & Associates
JKHY
$10.9B
$127K ﹤0.01%
767
-74
-9% -$12.3K
AVDL
1569
DELISTED
Avadel Pharmaceuticals
AVDL
$127K ﹤0.01%
+9,055
New +$148K
ODP
1570
DELISTED
ODP
ODP
$127K ﹤0.01%
3,242
– –
PRO
1571
DELISTED
PROS Holdings
PRO
$127K ﹤0.01%
4,443
– –
LADR
1572
Ladder Capital
LADR
$1.28B
$127K ﹤0.01%
11,260
– –
LILAK icon
1573
Liberty Latin America Class C
LILAK
$1.65B
$127K ﹤0.01%
14,508
-1,222
-8% -$9.11K
FBNC icon
1574
First Bancorp
FBNC
$2.75B
$126K ﹤0.01%
3,957
– –
WABC icon
1575
Westamerica Bancorp
WABC
$1.39B
$126K ﹤0.01%
2,600
– –
61 62
63
64 65

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
EPIM
Evelyn Partners Investment Management London $3.68B AUM 21.15% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.